WO2010094916A1 - Drug container and delivery mechanism - Google Patents

Drug container and delivery mechanism Download PDF

Info

Publication number
WO2010094916A1
WO2010094916A1 PCT/GB2010/000282 GB2010000282W WO2010094916A1 WO 2010094916 A1 WO2010094916 A1 WO 2010094916A1 GB 2010000282 W GB2010000282 W GB 2010000282W WO 2010094916 A1 WO2010094916 A1 WO 2010094916A1
Authority
WO
WIPO (PCT)
Prior art keywords
housing
drug
plunger
sealing element
seal
Prior art date
Application number
PCT/GB2010/000282
Other languages
French (fr)
Inventor
Matthew Young
Original Assignee
Oval Medical Technologies Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oval Medical Technologies Limited filed Critical Oval Medical Technologies Limited
Priority to CN201080007988.4A priority Critical patent/CN102316918B/en
Priority to AU2010215317A priority patent/AU2010215317A1/en
Priority to CA2789931A priority patent/CA2789931C/en
Priority to BRPI1008900A priority patent/BRPI1008900B8/en
Priority to KR1020117021732A priority patent/KR101690346B1/en
Priority to JP2011549659A priority patent/JP5848132B2/en
Priority to US13/202,007 priority patent/US8632504B2/en
Priority to EP10706709.2A priority patent/EP2398534B1/en
Publication of WO2010094916A1 publication Critical patent/WO2010094916A1/en
Priority to ZA2011/06444A priority patent/ZA201106444B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
    • A61M5/31513—Piston constructions to improve sealing or sliding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
    • A61M5/285—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle with sealing means to be broken or opened
    • A61M5/286—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle with sealing means to be broken or opened upon internal pressure increase, e.g. pierced or burst
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06—Ampoules or carpules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/1782—Devices aiding filling of syringes in situ
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M5/2033—Spring-loaded one-shot injectors with or without automatic needle insertion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
    • A61M5/2422—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic using emptying means to expel or eject media, e.g. pistons, deformation of the ampoule, or telescoping of the ampoule
    • A61M5/2429—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic using emptying means to expel or eject media, e.g. pistons, deformation of the ampoule, or telescoping of the ampoule by telescoping of ampoules or carpules with the syringe body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
    • A61M5/2455—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic with sealing means to be broken or opened
    • A61M5/2459—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic with sealing means to be broken or opened upon internal pressure increase, e.g. pierced or burst
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
    • A61M5/285—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle with sealing means to be broken or opened
    • A61M5/288—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle with sealing means to be broken or opened by piercing without internal pressure increase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3202—Devices for protection of the needle before use, e.g. caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3202—Devices for protection of the needle before use, e.g. caps
    • A61M5/3204—Needle cap remover, i.e. devices to dislodge protection cover from needle or needle hub, e.g. deshielding devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
    • A61M5/321—Means for protection against accidental injuries by used needles
    • A61M5/3243—Means for protection against accidental injuries by used needles being axially-extensible, e.g. protective sleeves coaxially slidable on the syringe barrel
    • A61M5/326—Fully automatic sleeve extension, i.e. in which triggering of the sleeve does not require a deliberate action by the user
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/34—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub
    • A61M5/348—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub snap lock, i.e. upon axial displacement of needle assembly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M2005/2006—Having specific accessories
    • A61M2005/2013—Having specific accessories triggering of discharging means by contact of injector with patient body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M2005/206—With automatic needle insertion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M2005/2073—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically preventing premature release, e.g. by making use of a safety lock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M2005/3101—Leak prevention means for proximal end of syringes, i.e. syringe end opposite to needle mounting end
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M2005/3103—Leak prevention means for distal end of syringes, i.e. syringe end for mounting a needle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M2005/3117—Means preventing contamination of the medicament compartment of a syringe
    • A61M2005/3121—Means preventing contamination of the medicament compartment of a syringe via the proximal end of a syringe, i.e. syringe end opposite to needle cannula mounting end
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
    • A61M2005/31516—Piston or piston-rod constructions, e.g. connection of piston with piston-rod reducing dead-space in the syringe barrel after delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
    • A61M2005/31521—Pistons with a forward extending skirt at their front end
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
    • A61M5/321—Means for protection against accidental injuries by used needles
    • A61M5/3243—Means for protection against accidental injuries by used needles being axially-extensible, e.g. protective sleeves coaxially slidable on the syringe barrel
    • A61M5/3245—Constructional features thereof, e.g. to improve manipulation or functioning
    • A61M2005/3247—Means to impede repositioning of protection sleeve from needle covering to needle uncovering position
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/002—Packages specially adapted therefor, e.g. for syringes or needles, kits for diabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3287—Accessories for bringing the needle into the body; Automatic needle insertion
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B3/003—Filling medical containers such as ampoules, vials, syringes or the like

Definitions

  • This invention relates to devices for drug storage and drug administration to a patient.
  • One type of drug delivery device known in the art is an injection apparatus which contains a medical, therapeutic, diagnostic, pharmaceutical or cosmetic compound (drug) before it is administered, and which is used to administer the compound through the skin of the patient via a hollow needle.
  • a medical, therapeutic, diagnostic, pharmaceutical or cosmetic compound drug
  • Injection apparatus of this type include pre-filled syringes and autoinjectors. These may contain a drug within a glass or plastic housing that is sealed at one end by a moveable rubber plunger, the internal surfaces of the housing and the plunger having been lubricated prior to being filled with drug by the application of silicone.
  • the rubber plunger performs the dual functions of sealing an opening in the container prior to administration of the drug to the patient, and also of applying a force required to expel the drug from the container during administration of the drug to the patient.
  • Rubber plungers of this type typically incorporate multiple continuous sealing contact rings spaced apart from each other so that movement of the plunger within the container due to changes in atmospheric pressure during storage does not allow any surface of the container to be in contact at different times with both the drug and the unsterile environment outside the container.
  • the multiple rings also increase the effective thickness of the rubber seal between the drug and the atmosphere outside the housing in order to provide a substantial barrier to gasses and moisture.
  • a disadvantage of these multiple rings is that they increase the force required to move the plunger within the housing.
  • Other factors which affect the forces required to move the rubber plunger during administration of the drug to a patient can include the distribution and quantity of any silicone or other lubricant present on the surface of the housing or the plunger.
  • Some prefilled syringes and autoinjectors incorporate a second opening within the housing through which the drug is expelled via a hollow hypodermic needle which is fixed to the housing.
  • the needle is blocked by a rubber cap in order to seal the contents of the housing.
  • This design has the disadvantage that it allows the drug to contact the inside of the needle and other materials such as the needle-retaining glue during storage.
  • This design also requires the rubber cap to be removed before the drug is administered, requiring an additional separate action by the device user.
  • This design also typically leaves a relatively large opening in the drug delivery device after the rubber cap has been removed and the drug administered, through which the contaminated needle can be accessed resulting in an increased risk of accidental transmission of blood-borne diseases due to needle stick injury.
  • closure seal means a seal which prevents deterioration or contamination of a drug in a container against foreseeable external factors in storage.
  • a closure seal maintains the safety, identity, strength, quality, and/or purity of a drug in a container in compliance with official, regulatory or established requirements.
  • the present invention aims to address some or all of the problems described above by providing a drug delivery device or primary drug container with a plunger which typically requires lower forces to move it within the housing compared with a typical rubber plunger, and a separate sealing element to compensate for the reduced sealing performance of this plunger against gasses, moisture and biological contamination compared with a typical rubber plunger.
  • neither the housing nor the plunger is lubricated with a separate lubricant for reducing frictional forces of the plunger during administration of the drug.
  • a separate lubricant for reducing frictional forces of the plunger during administration of the drug.
  • a low friction plunger is achieved through use of a substantially non-elastomeric material such as polypropylene, polyethylene or FEP (Fluorinated Ethylene Propylene) in a thin-wall seal design such as a 'cup' seal, where the seal between the plunger and the housing is augmented by the pressure of the medication on the seal during administration.
  • a substantially non-elastomeric material such as polypropylene, polyethylene or FEP (Fluorinated Ethylene Propylene) in a thin-wall seal design such as a 'cup' seal
  • the plunger is formed so that a component of the fluid pressure exerted by the drug during delivery of the drug is directed towards the sealing interface between the plunger and the housing.
  • the fluid pressure exerted by the drug thereby augments the seal between the plunger and the housing.
  • the plunger may be formed with a hollow portion in contact with the drug, such that the drug is in contact with and presses against an interior wall of the plunger.
  • low friction plunger are also suitable for use in the present invention.
  • the plunger may incorporate other surfaces designed to contact with the housing in order to keep the plunger aligned axially within the housing during administration of the drug, in order to maintain the integrity of any seal between the plunger and the housing.
  • the contact surfaces may be formed from a non-elastomeric material, and may have dimensions and/or form that prevent them from forming a substantive seal with the housing.
  • the separate sealing element of the closure seal is preferably formed from a material which is substantially impermeable to oxygen, moisture and biological contamination, and which can be pierced by a pusher to expel the drug.
  • a material which is substantially impermeable to oxygen, moisture and biological contamination, and which can be pierced by a pusher to expel the drug.
  • Such materials include 'trilaminate' foils. These foils may include an inner 'adhesive' layer, for example of polypropylene, which is appropriate for drug contact and which can be sealed to the housing using heat or another method. They may also include a middle layer such as aluminium or a fluoropolymer to provide oxygen barrier performance. Alternative oxygen barriers include ethylene vinyl alcohol and polyamide. A further outer layer is generally used to provide strength, and may be made from paper, polyamide, PVC etc. Such materials also include foils which consist of a single material such as a fluoropolymer.
  • the sealing element is designed to be rupturable, i.e. under pressure it will break rather than peel or otherwise come away from the housing, and is typically thinner and less rigid than the housing.
  • the separate sealing element can be heat welded to the housing, or can be joined through other means such as ultrasonic, induction or laser welding, or through the use of separate adhesives, such as UV curable adhesives.
  • the sealing element can be held in place by force alone, for instance by using a mechanical fastening component, preferentially in conjunction with a compression washer to maintain a sufficiently consistent force on the seal to accommodate manufacturing tolerances and dimensional changes of the components over time.
  • This mechanical fastening component can typically be clipped or screwed into place, and would typically fasten to the housing.
  • a pusher is positioned on the opposite side of the sealing element. This pusher can be moved to break the seal and move the plunger within the housing to dispense the drug. In one embodiment of the design this movement is caused by a user of the device applying a force to the device. In another embodiment this force comes from a stored power source such as a spring.
  • One embodiment of the invention therefore incorporates a second sealing element which is designed to be appropriate for assembly within an aseptic environment.
  • the second sealing element can be held in place by force alone, for instance by using a mechanical fastening component, preferentially in conjunction with a compression washer to maintain a sufficiently consistent force on the seal to accommodate manufacturing tolerances and dimensional changes of the components over time.
  • This mechanical fastening component can be clipped or screwed into place, and would typically fasten to the housing.
  • the second sealing element can be heat welded to the housing, or can be joined through other means such as ultrasonic, induction or laser welding, or through the use of separate adhesives such as UV curing adhesives.
  • a further aspect of the invention incorporates a mechanism to rupture the second sealing element and allow the drug to pass through a hollow hypodermic needle during administration of the drug to a patient.
  • This approach prevents the drug from contacting the needle or other associated materials during storage of the device, and avoids the use of a large needle-blocking rubber cap which requires a separate removal action by the user before the drug is administered, and which can cause the used needle to be exposed after administration.
  • a primary drug container may comprise: a housing containing a drug to be dispensed, the housing having a first end defining an opening; a plunger, positioned within the housing, in contact with the drug; and a first sealing element providing a first closure seal across the first opening of the housing; wherein the plunger does not form a closure seal with the housing and includes a hollow portion such that, in use, the drug is in contact with and presses against an interior wall of the hollow portion.
  • This type of plunger can be described as forming a self energising seal, and an example is a cup seal plunger.
  • the plunger does not suffer from sticking and lubricant may not be required.
  • This type of primary drug container is particularly suitable for automated drug delivery mechanisms, requiring movement of the plunger in only a single direction. Because the plunger relies on pressure from the drug to form a seal, it is not suitable for movement in a reverse direction, away from the drug, and so can be thought of as a "non-reversible" plunger. Movement in a reverse direction would likely allow air or any other gas, liquid or other contaminant on the other side of the seal to pass the seal and contaminate the drug and/or the patient.
  • closure seal is preferably designed to be piercable, but may be peelable or removed in other ways during use. It should be apparent that other features of this aspect of the invention, such as the choice of materials for the housing, closure seal and plunger, and the means of fastening the closure seal to the housing can be the same as described with reference to the embodiments described above.
  • non-needle based drug delivery devices such as autoinjectors and syringes, i.e. devices including a hollow hypodermic needle through which the drug is delivered to the patient
  • the invention is equally applicable to non-needle based drug delivery devices.
  • non-needle based refers to drug delivery devices that do not include a hypodermic needle through which the drug is delivered in use.
  • Drug delivery devices that may comprise a primary drug container in accordance with the invention include inhalers, insufflators, droppers, tubes, bottles, vials, applicators and other dispensers of drugs including drugs in the form of liquids, creams, gels, powders, tablets, granules, gasses, aerosols, sprays and suspensions for parenteral (including intradermal, subcutaneous, intramuscular and intravenous), topical, nasal, oral, aural, sublingual, rectal, vaginal and other applications.
  • the invention may be used in devices that require manual force to dispense the drug as well as with a variety of automated dispensing mechanisms.
  • Figure 1 is a longitudinal cross-section of an example of a primary drug container
  • Figure 2 is an exploded view of the primary drug container from Figure 1 ;
  • Figure 3 is a longitudinal cross-section through an example of a drug delivery device incorporating the present invention before administration of the drug to the patient;
  • Figure 4 is the invention in Figure 3 after administration of the drug to the patient;
  • Figure 5 is a detail view of Figure 3 showing an alternative plunger design which includes an O-ring;
  • Figure 6 is a detail view of Figure 3 showing an alternative plunger design which includes an interference seal
  • Figure 7 is a detail view of Figure 3 showing an alternative plunger design which is comprised of a two-component injection moulding of a TPE (thermoplastic elastomer) and a substantially non-elastomeric material;
  • TPE thermoplastic elastomer
  • Figure 8 is a section view of another example of the invention with a first sealing element retained by a mechanical fastening which is retained by a screw thread;
  • Figure 9 is an exploded view of the housing, first sealing element, compression washer and mechanical fastening of Figure 8;
  • Figure 10 is a section view of another example of the invention with a first sealing element retained by a mechanical fastening which is retained by clips to the housing;
  • Figure 11 is an exploded view of the housing, first sealing element, compression washer and mechanical fastening of Figure 10;
  • Figure 12 is a view of the primary container of another example of the invention before filling, showing a separate housing subassembly and a separate second sealing subassembly;
  • Figure 13 is a section view of the primary container of another example of the invention before filling, showing a separate housing subassembly and a separate second sealing subassembly;
  • Figures 14a, 14b, 14c and 14d are section views of the filling sequence of the primary container of Figure 12;
  • Figure 15 is a section view of an example of an auto-injector incorporating the present invention before administration of the drug to the patient;
  • Figure 16 is a section view of the auto-injector of Figure 15 immediately after administration of the drug to the patient;
  • Figure 17 is a section view of the auto-injector of Figure 15 after the user has removed the auto-injector from the patient and a needle safety mechanism has deployed;
  • Figure 18 is an exploded view of the auto-injector of Figure 15;
  • Figure 19 is a section view of Figure 3 showing an alternative design of the second sealing element welded to the housing;
  • Figure 20 is a section view of Figure 3 showing an alternative design with a second sealing element retained by a mechanical fastening which is retained by a screw thread;
  • Figure 21 is a view of an alternative embodiment of the invention in which the drug is filled into the housing through the same opening in the housing through which the plunger is assembled;
  • Figure 22 is a three-dimensional section view of Figure 21 ;
  • Figure 23 is a section view of Figure 21 before administration of the drug to a patient;
  • Figure 24 is a section view of Figure 21 after administration of the drug to a patient;
  • Figure 25 is an exploded view of Figure 21 ;
  • Figure 26 shows the drug filling sequence for the invention described in Figure 21. Detailed Description
  • the primary drug container is defined as the housing, plunger, and any sealing components required in order to contain the drug within the housing.
  • FIG. 1 shows one example of a primary drug container 1 for use in a drug delivery device in accordance with the present invention.
  • the primary drug container 1 comprises a housing 2, a first sealing element 3, a plunger 4, a second sealing element 5, a compression washer 6 and a mechanical fastening component 7.
  • the housing 2, the first sealing element 3 and the second sealing element 5 form a sealed container which is substantially impermeable to moisture, atmospheric gasses including oxygen, and biological contamination.
  • a drug 8 is contained within the container prior to administration to a patient.
  • the primary drug container can form part of a drug delivery device, but can be filled and sealed in a separate environment from assembly to the rest of the drug delivery device, in order to protect the drug from contamination.
  • the plunger 4 includes a sealing feature 9 with a sealing lip 10 in contact with the housing 2.
  • the plunger 4 is positioned close to the first sealing element 3 and is designed to minimise the volume of drug which can reside between the sealing lip 10 and the first sealing element 3.
  • the pressure of the drug fluid acts on the sealing feature 9 to increase the sealing force between the sealing lip 10 and the housing 2.
  • the first sealing element 3 is welded to the housing 2.
  • the second sealing element 5 is maintained in position against the housing 2 by the mechanical fastening component 7 acting on it through the compression washer 6.
  • the housing 2 in this embodiment may be formed from plastic or glass.
  • the first sealing element in this embodiment is formed from a trilaminate foil including an inner 'adhesive' layer, for example of polypropylene, which is appropriate for drug contact and which can be sealed to the housing using heat or another method, a middle layer such as aluminium or a fluoropolymer to provide oxygen barrier performance and an further outer layer to provide strength, which may be made from paper, polyamide, or PVC.
  • the plunger in this embodiment is formed from a substantially non- elastomeric material such as polypropylene, polyethylene or FEP (Fluorinated Ethylene Propylene) in a thin-wall 'cup' seal, where the seal between the plunger and the housing is augmented by the pressure of the medication on the seal during administration.
  • a substantially non- elastomeric material such as polypropylene, polyethylene or FEP (Fluorinated Ethylene Propylene) in a thin-wall 'cup' seal, where the seal between the plunger and the housing is augmented by the pressure of the medication on the seal during administration.
  • Figure 2 shows an exploded view of the primary drug container 1 of Figure 1 without the drug 8.
  • FIG 3 shows an example of a drug delivery device 11 in accordance with the present invention in its stored state before the drug 8 is administered to a patient.
  • the drug delivery device 11 includes the primary drug container 1 of Figure 1. It also includes a plunger rod 12 which incorporates a pusher 13 with a piercing feature 14. During administration of the drug to a patient, the piercing feature 14 pierces the sealing element 3 and urges the plunger axially along the housing 2 to expel the drug 8 due to the application of force to the plunger rod 12 by the person administering the drug.
  • a hollow hypodermic needle 15 to extend through the patient's skin, and the opposite end of the needle to pierce the second sealing element 5 allowing the drug 8 to flow through the needle 15 and into the patient.
  • the needle 15 is mounted in a needle hub 16 which is sealed by a needle hub seal 34 to prevent leakage of the drug 8 during administration.
  • the needle hub seal 34 further seals to a removable needle shield 17 which keeps the needle 15 sterile and protects it from damage prior to administration of the drug 8.
  • a spring 18 urges the end of the needle 15 out of the patient back into the device when the person administering the drug 8 releases the force that they are applying to the plunger rod 12.
  • Figure 4 shows the drug delivery device of Figure 3 in its used state after the drug 8 has been delivered but before the needle 15 has been withdrawn from the patient.
  • the pusher 13 has forced the housing 2 forwards, which in turn has caused the end of the needle 15 to be extended forwards into the patient and the other end of the needle 19 to pierce the second sealing element 5.
  • the pusher 13 has pierced the first sealing element 3 and urged the plunger 4 forwards to expel the drug 8.
  • Figure 5 shows a detail view of the design of Figure 1 incorporating an alternative design of plunger 20 which is made from a substantially rigid material and which includes an elastomeric O-ring 21.
  • Figure 6 shows a detail view of the design of Figure 1 incorporating an alternative design of plunger 22 which includes a stronger sealing feature 23 compared with the first plunger 4 described above.
  • the plunger 22 differs from the plunger 4 described above in that the seal relies more on an interference fit between the housing 2 and the sealing feature 23. However, this seal still provides low friction with the housing and is not sufficient to provide a closure seal to maintain the condition of drug.
  • Figure 7 shows a detail view of the design of Figure 1 incorporating an alternative design of plunger 25 which includes both a substantially rigid material such as polypropylene or polyethylene and a second elastomeric material such as TPE (thermoplastic elastomer).
  • the rigid part of the plunger 26 supports the elastomeric part 27 to form a seal at the sealing contact area 28 with the housing 2.
  • the plunger is manufactured using a 'two-shot' injection moulding process involving two separate materials within a single mould tool, or by otherwise over-moulding the elastomeric part 27 onto the substantially rigid part 26.
  • FIG 8 is a section view of another example of a primary container identical to Figure 1 other than that the first sealing element 3 is retained by a mechanical fastening component 30 in conjunction with a compression washer 31.
  • the compression washer maintains a sufficiently consistent force on the first sealing element to accommodate manufacturing tolerances and dimensional changes of the components over time.
  • This mechanical fastening component 30 is retained by a screw-thread 32, and is screwed to a corresponding thread detail 33 on the housing 38 during the assembly process. This assembly process can take place either before or after filling of the drug 8 into the primary container.
  • Figure 9 is an exploded view of the housing 38, first sealing element 3, compression washer 31 and mechanical fastening component 30 of Figure 8
  • Figure 10 is a section view of another example of a primary container identical to Figure 8 except that the mechanical fastening component 35 is retained by fastening surfaces 36 which engage with latch details 37 on the housing 39. This allows the first mechanical fastening component 35 to be assembled directly to the primary container 39 as a 'push-fit' which does not require a screwing action.
  • Figure 11 is an exploded view of the housing 39, first sealing element 3, compression washer 31 and mechanical fastening component 35 of Figure 10.
  • Figure 12a and Figure 12b together show an example of partially assembled primary drug container which is capable of being filled and then assembled together.
  • the primary drug container comprises a container portion 52 and a lid portion 53.
  • the primary drug container is identical to the primary drug container of Figure 1 and Figure 3 with the addition of a needle mechanism similar to that shown in Figure 3.
  • the two subassemblies of Figure 12a and Figure 12b as described are supplied to the filling process, where drug is filled through an opening 40 in the container portion 52 and then the lid portion 53 is assembled to the container portion 52 to seal the primary drug container.
  • Figure 13a and Figure 13b show the corresponding section views of the container portion 52 and lid portion 53 of Figure 12a and Figure 12b
  • Figures 14a to 14d show the filling sequence for Figure 12.
  • Figure 14a shows the container portion 52 ready for filling.
  • the container with the first closure seal 3 and the plunger 4 can be assembled outside the aseptic environment.
  • the container assembly is then sterilised before being filled with drug in an aseptic environment.
  • Figure 14b shows the container portion 52 after it has been filled with drug.
  • Figure 14c shows the lid portion 53 in position above the container portion 52 ready for assembly. Again, the entire lid assembly can advantageously be assembled outside the aseptic environment and then sterilised before being united with the container assembly in an aseptic environment.
  • Figure 14d shows the lid portion 53 and the container portion 52 assembled together with the drug.
  • Figure 15 shows a section view through another example of the invention where the drug delivery device is an auto-injector.
  • the primary drug container is significantly similar to the primary drug container of Figure 1 , and to both the primary container and needle mechanism of Figure 3, both described in detail above.
  • a main drive spring 41 applies a force to a pusher 42, which is retained by two locking rollers 43.
  • an auto-injector user removes the cap 44 with the attached needle shield 45 and presses the exposed front surface 46 of the needle cover 47 onto the patient injection site, pushing the needle cover 47 back into the auto-injector. This allows the locking rollers 43 to move out of the way of the pusher 42, so that the spring 41 can move the pusher 42 forwards.
  • Figure 16 shows Figure 15 immediately after administration of the drug to the patient.
  • the needle 15 is extended into the patient.
  • the other end of the needle 19 furthest from the patient has pierced the second sealing element 5 and the plunger 4 has been urged axially through the housing 2 by the pusher 42.
  • the first sealing element 3 has been broken by the pusher piercing elements 48.
  • FIG 17 shows Figure 15 after the user has stopped applying the auto- injector to the skin of the patient and the needle cover spring 50 has forced the needle cover 47 to extend so that it shields the used needle 15 to reduce the risk of accidental transmission of blood-borne diseases due to needle stick injury. Locking details 51 at the back of the needle cover 47 prevent the needle cover 47 from moving back into the auto- injector.
  • Figure 18 is an exploded view of Figure 15 showing the components of the auto-injector.
  • a rear cover 62, a front cover 63 and a cap 44 form the outer casing of the auto-injector.
  • An inner housing 83 supports the spring 41.
  • Figure 19 shows a section view of Figure 1 incorporating an alternative design of housing 54 and second sealing element 55 where the second sealing element 55 is welded or attached with adhesive to the housing, and therefore does not require the compression washer 6 or mechanical fastening component 7 shown in Figure 1.
  • Figure 20 shows a section view of Figure 1 incorporating an alternative design of housing 56 and second sealing element 58 where the second sealing element 58 is attached by a mechanical fastening component 57 and compression washer 59 where the mechanical fastening component 57 is retained preferentially to the housing 56 by a screw thread 61 which engages in a corresponding thread detail 60 on the housing.
  • Figure 21 shows another embodiment of the invention where the opening in a housing through which the drug is filled is the same as that used to assemble the plunger.
  • Figure 22 is a three-dimensional section view of Figure 21 showing the components in more detail.
  • a housing 64 is sealed by a first sealing element 65 which is retained by a compression washer 66 and mechanical fastening component 67.
  • a plunger 68 is positioned adjacent to the first sealing element 65, and may be attached to the sealing element 65 through a weld or adhesive.
  • a lower body 69 is axially moveable in relation to the housing 64, and contains a needle hub 70 which in turn is axially moveable in relation to the lower body 69.
  • a seal 71 incorporated into the needle hub 70 prevents accidental movement of the needle hub 70 before administration of the drug 72.
  • Piercing teeth 80 on the needle hub 70 pierce the first sealing element 65 during administration of the drug, allowing the needle hub 70 to move a portion of the first sealing element 65 including the part joined to the plunger 68 and also the plunger 68 itself axially through the housing 64.
  • a second sealing element 73 maintains the cleanliness and sterility of a needle 74 before administration of the drug 72, and is pierced by the needle 74 during administration of the drug 72.
  • the needle 74 is fixed into the needle hub 70 so that the end of the needle 75 nearest the second sealing element 73 can enter the patient during drug administration, and so that the other end of the needle 76 furthest from the patient can pierce the first sealing element 65 during drug administration to allow the drug 72 to flow through the needle 74.
  • a button component 77 provides a suitable surface 78 for the person administering the drug to apply a force to in order to facilitate drug administration.
  • a locking ring 79 prevents accidental activation of the device, and is removed prior to administration of the drug 72.
  • Figure 23 shows a section view of Figure 21 before administration of the drug 72.
  • Figure 24 shows a section view of Figure 21 after administration of the drug 72, and illustrates the first sealing element 65 after it has been pierced by the needle hub 70, the second sealing element 73 after it has been pierced by the needle 74, and the plunger 68 after it has been urged axially through the housing 64 by the needle hub 70 in order to deliver the drug 72.
  • Figure 25 shows an exploded view of Figure 21.
  • Figures 26a to 26d show the filling sequence for Figure 21.
  • Figure 26a shows the container portion 81 ready for filling.
  • Figure 26b shows the container portion 81 after it has been filled with drug 72.
  • Figure 26c shows the lid portion 82 in position above the container portion 81 ready for assembly.
  • Figure 26d shows the lid portion 82 and the container portion 81 assembled together with the drug 72.
  • the lid portion 82 can be preassembled outside of the aseptic environment and then sterilised before being fixed to the container portion 81 using a push- fit connection or other suitable mechanical fastening.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Environmental & Geological Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

A device for storing and administering drug includes a housing, a sealing element (3) and a separate low friction plunger (4) which is substantially- permeable to gas over time. The sealing element (3) is typically broken to allow delivery of the drug. The housing (2) may be filled with the drug through an opening other than the opening through which the pusher (13) enters the housing to move the plunger so as to expel the drug during administration to a patient.

Description

DRUG CONTAINER AND DELIVERY MECHANISM
Field of the Invention
This invention relates to devices for drug storage and drug administration to a patient.
Background to the Invention
One type of drug delivery device known in the art is an injection apparatus which contains a medical, therapeutic, diagnostic, pharmaceutical or cosmetic compound (drug) before it is administered, and which is used to administer the compound through the skin of the patient via a hollow needle.
Injection apparatus of this type include pre-filled syringes and autoinjectors. These may contain a drug within a glass or plastic housing that is sealed at one end by a moveable rubber plunger, the internal surfaces of the housing and the plunger having been lubricated prior to being filled with drug by the application of silicone. The rubber plunger performs the dual functions of sealing an opening in the container prior to administration of the drug to the patient, and also of applying a force required to expel the drug from the container during administration of the drug to the patient.
Rubber plungers of this type typically incorporate multiple continuous sealing contact rings spaced apart from each other so that movement of the plunger within the container due to changes in atmospheric pressure during storage does not allow any surface of the container to be in contact at different times with both the drug and the unsterile environment outside the container. The multiple rings also increase the effective thickness of the rubber seal between the drug and the atmosphere outside the housing in order to provide a substantial barrier to gasses and moisture. A disadvantage of these multiple rings is that they increase the force required to move the plunger within the housing. Other factors which affect the forces required to move the rubber plunger during administration of the drug to a patient can include the distribution and quantity of any silicone or other lubricant present on the surface of the housing or the plunger. In practice these forces can vary greatly due to variation in consistency of lubricant application during manufacture and to displacement of the lubricant and consequent bonding of the plunger to the housing over time. This has a corresponding impact on the design requirements and reliability of the drug delivery device. In addition any lubricants, such as silicone, in contact with the drug can have a detrimental effect on the drug, which can shorten the time for which the drug remains in a usable condition within the device.
Some prefilled syringes and autoinjectors incorporate a second opening within the housing through which the drug is expelled via a hollow hypodermic needle which is fixed to the housing. During storage of the filled device prior to administration of the drug, the needle is blocked by a rubber cap in order to seal the contents of the housing. This design has the disadvantage that it allows the drug to contact the inside of the needle and other materials such as the needle-retaining glue during storage. This design also requires the rubber cap to be removed before the drug is administered, requiring an additional separate action by the device user. This design also typically leaves a relatively large opening in the drug delivery device after the rubber cap has been removed and the drug administered, through which the contaminated needle can be accessed resulting in an increased risk of accidental transmission of blood-borne diseases due to needle stick injury.
Summary of the Invention
The present invention is described in the attached appended claims.
The term "closure seal" as used herein in the claims and description means a seal which prevents deterioration or contamination of a drug in a container against foreseeable external factors in storage. A closure seal maintains the safety, identity, strength, quality, and/or purity of a drug in a container in compliance with official, regulatory or established requirements.
The present invention aims to address some or all of the problems described above by providing a drug delivery device or primary drug container with a plunger which typically requires lower forces to move it within the housing compared with a typical rubber plunger, and a separate sealing element to compensate for the reduced sealing performance of this plunger against gasses, moisture and biological contamination compared with a typical rubber plunger.
In one embodiment of the invention, neither the housing nor the plunger is lubricated with a separate lubricant for reducing frictional forces of the plunger during administration of the drug. The use of a low friction plunger that is not provided with a closure seal provides acceptably low and consistent forces during drug administration without this lubricant.
In one embodiment of the invention a low friction plunger is achieved through use of a substantially non-elastomeric material such as polypropylene, polyethylene or FEP (Fluorinated Ethylene Propylene) in a thin-wall seal design such as a 'cup' seal, where the seal between the plunger and the housing is augmented by the pressure of the medication on the seal during administration.
Preferably, the plunger is formed so that a component of the fluid pressure exerted by the drug during delivery of the drug is directed towards the sealing interface between the plunger and the housing. The fluid pressure exerted by the drug thereby augments the seal between the plunger and the housing. To achieve this, the plunger may be formed with a hollow portion in contact with the drug, such that the drug is in contact with and presses against an interior wall of the plunger. The advantage of this type of seal is that there is a strong correlation between the force that enables the seal (and hence creates friction that resists movement of the seal) and the force acting on the plunger to urge the drug out of the primary drug container. If the plunger ceases to move due to friction then the hydraulic pressure of the drug reduces as drug exits the container into the patient, reducing the friction and allowing the plunger to move again, so a self-compensating mechanism is achieved. This type of seal is therefore less likely to 'stall' compared with conventional rubber syringe plungers. This type of plunger, which relies on pressure from the drug to form a seal, is not suitable for movement in a reverse direction, away from the drug, and so can be thought of as a "non-reversible" plunger. Movement in a reverse direction would likely allow air or any other gas, liquid or other contaminant on the other side of the seal to pass the seal and contaminate the drug and/or the patient.
Other designs of low friction plunger are also suitable for use in the present invention. For example, a design incorporating a two-component injection moulding of a TPE (thermoplastic elastomer) and a substantially non-elastomeric material, or incorporating an elastomeric O-ring in conjunction with a rigid plunger body, or incorporating an interference fit between the housing and a plunger made from a low-friction material such as polypropylene or polyethylene. The fact that these designs may provide only a single continuous sealing contact ring does not compromise the sterility and condition of the drug because of the use of the separate closure seal.
The plunger may incorporate other surfaces designed to contact with the housing in order to keep the plunger aligned axially within the housing during administration of the drug, in order to maintain the integrity of any seal between the plunger and the housing. The contact surfaces may be formed from a non-elastomeric material, and may have dimensions and/or form that prevent them from forming a substantive seal with the housing.
The separate sealing element of the closure seal is preferably formed from a material which is substantially impermeable to oxygen, moisture and biological contamination, and which can be pierced by a pusher to expel the drug. Such materials include 'trilaminate' foils. These foils may include an inner 'adhesive' layer, for example of polypropylene, which is appropriate for drug contact and which can be sealed to the housing using heat or another method. They may also include a middle layer such as aluminium or a fluoropolymer to provide oxygen barrier performance. Alternative oxygen barriers include ethylene vinyl alcohol and polyamide. A further outer layer is generally used to provide strength, and may be made from paper, polyamide, PVC etc. Such materials also include foils which consist of a single material such as a fluoropolymer.
The sealing element is designed to be rupturable, i.e. under pressure it will break rather than peel or otherwise come away from the housing, and is typically thinner and less rigid than the housing.
The separate sealing element can be heat welded to the housing, or can be joined through other means such as ultrasonic, induction or laser welding, or through the use of separate adhesives, such as UV curable adhesives. Alternatively, the sealing element can be held in place by force alone, for instance by using a mechanical fastening component, preferentially in conjunction with a compression washer to maintain a sufficiently consistent force on the seal to accommodate manufacturing tolerances and dimensional changes of the components over time. This mechanical fastening component can typically be clipped or screwed into place, and would typically fasten to the housing.
In order to move the plunger to expel the drug during administration a pusher is positioned on the opposite side of the sealing element. This pusher can be moved to break the seal and move the plunger within the housing to dispense the drug. In one embodiment of the design this movement is caused by a user of the device applying a force to the device. In another embodiment this force comes from a stored power source such as a spring.
During manufacture, prior prefilled syringes and autoinjectors are almost always filled with drug through the same opening in the housing as the plunger is assembled. This process typically occurs in an aseptic environment. In a preferred aspect of the present invention, there are advantages in filling the drug through a second opening such as the opening through which the drug is expelled because this allows the plunger to be assembled, the sealing element attached, and then the system sterilised, all before the device enters the aseptic environment for filling with drug. However this requires that the second opening be sealed after filling.
One embodiment of the invention therefore incorporates a second sealing element which is designed to be appropriate for assembly within an aseptic environment. The second sealing element can be held in place by force alone, for instance by using a mechanical fastening component, preferentially in conjunction with a compression washer to maintain a sufficiently consistent force on the seal to accommodate manufacturing tolerances and dimensional changes of the components over time. This mechanical fastening component can be clipped or screwed into place, and would typically fasten to the housing. Alternatively, the second sealing element can be heat welded to the housing, or can be joined through other means such as ultrasonic, induction or laser welding, or through the use of separate adhesives such as UV curing adhesives.
A further aspect of the invention incorporates a mechanism to rupture the second sealing element and allow the drug to pass through a hollow hypodermic needle during administration of the drug to a patient. This approach prevents the drug from contacting the needle or other associated materials during storage of the device, and avoids the use of a large needle-blocking rubber cap which requires a separate removal action by the user before the drug is administered, and which can cause the used needle to be exposed after administration.
In a still further aspect of the invention, a primary drug container may comprise: a housing containing a drug to be dispensed, the housing having a first end defining an opening; a plunger, positioned within the housing, in contact with the drug; and a first sealing element providing a first closure seal across the first opening of the housing; wherein the plunger does not form a closure seal with the housing and includes a hollow portion such that, in use, the drug is in contact with and presses against an interior wall of the hollow portion. With this type of plunger, in use, the fluid pressure exerted by the drug augments or substantially creates the seal between the plunger and the housing, but the plunger provides a predictable, low friction contact with the housing. This type of plunger can be described as forming a self energising seal, and an example is a cup seal plunger. The plunger does not suffer from sticking and lubricant may not be required. This type of primary drug container is particularly suitable for automated drug delivery mechanisms, requiring movement of the plunger in only a single direction. Because the plunger relies on pressure from the drug to form a seal, it is not suitable for movement in a reverse direction, away from the drug, and so can be thought of as a "non-reversible" plunger. Movement in a reverse direction would likely allow air or any other gas, liquid or other contaminant on the other side of the seal to pass the seal and contaminate the drug and/or the patient.
In this aspect, the closure seal is preferably designed to be piercable, but may be peelable or removed in other ways during use. It should be apparent that other features of this aspect of the invention, such as the choice of materials for the housing, closure seal and plunger, and the means of fastening the closure seal to the housing can be the same as described with reference to the embodiments described above.
Although the present invention is primarily described herein in relation to needle based devices, such as autoinjectors and syringes, i.e. devices including a hollow hypodermic needle through which the drug is delivered to the patient, the invention is equally applicable to non-needle based drug delivery devices. The phrase "non-needle based" as used herein refers to drug delivery devices that do not include a hypodermic needle through which the drug is delivered in use. Drug delivery devices that may comprise a primary drug container in accordance with the invention include inhalers, insufflators, droppers, tubes, bottles, vials, applicators and other dispensers of drugs including drugs in the form of liquids, creams, gels, powders, tablets, granules, gasses, aerosols, sprays and suspensions for parenteral (including intradermal, subcutaneous, intramuscular and intravenous), topical, nasal, oral, aural, sublingual, rectal, vaginal and other applications. The invention may be used in devices that require manual force to dispense the drug as well as with a variety of automated dispensing mechanisms.
Brief Description of the Drawings
Examples of the present invention will now be described in detail with reference to accompanying drawings, in which:
Figure 1 is a longitudinal cross-section of an example of a primary drug container;
Figure 2 is an exploded view of the primary drug container from Figure 1 ;
Figure 3 is a longitudinal cross-section through an example of a drug delivery device incorporating the present invention before administration of the drug to the patient;
Figure 4 is the invention in Figure 3 after administration of the drug to the patient;
Figure 5 is a detail view of Figure 3 showing an alternative plunger design which includes an O-ring;
Figure 6 is a detail view of Figure 3 showing an alternative plunger design which includes an interference seal;
Figure 7 is a detail view of Figure 3 showing an alternative plunger design which is comprised of a two-component injection moulding of a TPE (thermoplastic elastomer) and a substantially non-elastomeric material;
Figure 8 is a section view of another example of the invention with a first sealing element retained by a mechanical fastening which is retained by a screw thread;
Figure 9 is an exploded view of the housing, first sealing element, compression washer and mechanical fastening of Figure 8;
Figure 10 is a section view of another example of the invention with a first sealing element retained by a mechanical fastening which is retained by clips to the housing; Figure 11 is an exploded view of the housing, first sealing element, compression washer and mechanical fastening of Figure 10;
Figure 12 is a view of the primary container of another example of the invention before filling, showing a separate housing subassembly and a separate second sealing subassembly;
Figure 13 is a section view of the primary container of another example of the invention before filling, showing a separate housing subassembly and a separate second sealing subassembly;
Figures 14a, 14b, 14c and 14d are section views of the filling sequence of the primary container of Figure 12;
Figure 15 is a section view of an example of an auto-injector incorporating the present invention before administration of the drug to the patient;
Figure 16 is a section view of the auto-injector of Figure 15 immediately after administration of the drug to the patient;
Figure 17 is a section view of the auto-injector of Figure 15 after the user has removed the auto-injector from the patient and a needle safety mechanism has deployed;
Figure 18 is an exploded view of the auto-injector of Figure 15;
Figure 19 is a section view of Figure 3 showing an alternative design of the second sealing element welded to the housing;
Figure 20 is a section view of Figure 3 showing an alternative design with a second sealing element retained by a mechanical fastening which is retained by a screw thread;
Figure 21 is a view of an alternative embodiment of the invention in which the drug is filled into the housing through the same opening in the housing through which the plunger is assembled;
Figure 22 is a three-dimensional section view of Figure 21 ;
Figure 23 is a section view of Figure 21 before administration of the drug to a patient;
Figure 24 is a section view of Figure 21 after administration of the drug to a patient;
Figure 25 is an exploded view of Figure 21 ; and
Figure 26 shows the drug filling sequence for the invention described in Figure 21. Detailed Description
For the purposes of describing the invention the primary drug container is defined as the housing, plunger, and any sealing components required in order to contain the drug within the housing.
Figure 1 shows one example of a primary drug container 1 for use in a drug delivery device in accordance with the present invention. The primary drug container 1 comprises a housing 2, a first sealing element 3, a plunger 4, a second sealing element 5, a compression washer 6 and a mechanical fastening component 7. The housing 2, the first sealing element 3 and the second sealing element 5 form a sealed container which is substantially impermeable to moisture, atmospheric gasses including oxygen, and biological contamination. A drug 8 is contained within the container prior to administration to a patient. The primary drug container can form part of a drug delivery device, but can be filled and sealed in a separate environment from assembly to the rest of the drug delivery device, in order to protect the drug from contamination. The plunger 4 includes a sealing feature 9 with a sealing lip 10 in contact with the housing 2. The plunger 4 is positioned close to the first sealing element 3 and is designed to minimise the volume of drug which can reside between the sealing lip 10 and the first sealing element 3. During administration of the drug 8 the pressure of the drug fluid acts on the sealing feature 9 to increase the sealing force between the sealing lip 10 and the housing 2. The first sealing element 3 is welded to the housing 2. The second sealing element 5 is maintained in position against the housing 2 by the mechanical fastening component 7 acting on it through the compression washer 6.
The housing 2 in this embodiment may be formed from plastic or glass. The first sealing element in this embodiment is formed from a trilaminate foil including an inner 'adhesive' layer, for example of polypropylene, which is appropriate for drug contact and which can be sealed to the housing using heat or another method, a middle layer such as aluminium or a fluoropolymer to provide oxygen barrier performance and an further outer layer to provide strength, which may be made from paper, polyamide, or PVC.
The plunger in this embodiment is formed from a substantially non- elastomeric material such as polypropylene, polyethylene or FEP (Fluorinated Ethylene Propylene) in a thin-wall 'cup' seal, where the seal between the plunger and the housing is augmented by the pressure of the medication on the seal during administration.
Figure 2 shows an exploded view of the primary drug container 1 of Figure 1 without the drug 8.
Figure 3 shows an example of a drug delivery device 11 in accordance with the present invention in its stored state before the drug 8 is administered to a patient. The drug delivery device 11 includes the primary drug container 1 of Figure 1. It also includes a plunger rod 12 which incorporates a pusher 13 with a piercing feature 14. During administration of the drug to a patient, the piercing feature 14 pierces the sealing element 3 and urges the plunger axially along the housing 2 to expel the drug 8 due to the application of force to the plunger rod 12 by the person administering the drug.
Application of force to the plunger rod 12 by the person administering the drug also causes a hollow hypodermic needle 15 to extend through the patient's skin, and the opposite end of the needle to pierce the second sealing element 5 allowing the drug 8 to flow through the needle 15 and into the patient. The needle 15 is mounted in a needle hub 16 which is sealed by a needle hub seal 34 to prevent leakage of the drug 8 during administration. The needle hub seal 34 further seals to a removable needle shield 17 which keeps the needle 15 sterile and protects it from damage prior to administration of the drug 8. A spring 18 urges the end of the needle 15 out of the patient back into the device when the person administering the drug 8 releases the force that they are applying to the plunger rod 12. Figure 4 shows the drug delivery device of Figure 3 in its used state after the drug 8 has been delivered but before the needle 15 has been withdrawn from the patient. The pusher 13 has forced the housing 2 forwards, which in turn has caused the end of the needle 15 to be extended forwards into the patient and the other end of the needle 19 to pierce the second sealing element 5. The pusher 13 has pierced the first sealing element 3 and urged the plunger 4 forwards to expel the drug 8.
Figure 5. shows a detail view of the design of Figure 1 incorporating an alternative design of plunger 20 which is made from a substantially rigid material and which includes an elastomeric O-ring 21.
Figure 6. shows a detail view of the design of Figure 1 incorporating an alternative design of plunger 22 which includes a stronger sealing feature 23 compared with the first plunger 4 described above. The plunger 22 differs from the plunger 4 described above in that the seal relies more on an interference fit between the housing 2 and the sealing feature 23. However, this seal still provides low friction with the housing and is not sufficient to provide a closure seal to maintain the condition of drug.
Figure 7 shows a detail view of the design of Figure 1 incorporating an alternative design of plunger 25 which includes both a substantially rigid material such as polypropylene or polyethylene and a second elastomeric material such as TPE (thermoplastic elastomer). The rigid part of the plunger 26 supports the elastomeric part 27 to form a seal at the sealing contact area 28 with the housing 2. In one embodiment of this design the plunger is manufactured using a 'two-shot' injection moulding process involving two separate materials within a single mould tool, or by otherwise over-moulding the elastomeric part 27 onto the substantially rigid part 26. Again the seal formed between the plunger and the contact area 28 is not sufficient to provide a closure seal sufficient to maintain the drug in a useable condition for its shelf-life. Closure seal 3 is provided for that purpose. Figure 8 is a section view of another example of a primary container identical to Figure 1 other than that the first sealing element 3 is retained by a mechanical fastening component 30 in conjunction with a compression washer 31. The compression washer maintains a sufficiently consistent force on the first sealing element to accommodate manufacturing tolerances and dimensional changes of the components over time. This mechanical fastening component 30 is retained by a screw-thread 32, and is screwed to a corresponding thread detail 33 on the housing 38 during the assembly process. This assembly process can take place either before or after filling of the drug 8 into the primary container.
Figure 9 is an exploded view of the housing 38, first sealing element 3, compression washer 31 and mechanical fastening component 30 of Figure 8
Figure 10 is a section view of another example of a primary container identical to Figure 8 except that the mechanical fastening component 35 is retained by fastening surfaces 36 which engage with latch details 37 on the housing 39. This allows the first mechanical fastening component 35 to be assembled directly to the primary container 39 as a 'push-fit' which does not require a screwing action.
Figure 11 is an exploded view of the housing 39, first sealing element 3, compression washer 31 and mechanical fastening component 35 of Figure 10.
Figure 12a and Figure 12b together show an example of partially assembled primary drug container which is capable of being filled and then assembled together. The primary drug container comprises a container portion 52 and a lid portion 53. The primary drug container is identical to the primary drug container of Figure 1 and Figure 3 with the addition of a needle mechanism similar to that shown in Figure 3. In this example of the invention the two subassemblies of Figure 12a and Figure 12b as described are supplied to the filling process, where drug is filled through an opening 40 in the container portion 52 and then the lid portion 53 is assembled to the container portion 52 to seal the primary drug container.
Figure 13a and Figure 13b show the corresponding section views of the container portion 52 and lid portion 53 of Figure 12a and Figure 12b
Figures 14a to 14d show the filling sequence for Figure 12. Figure 14a shows the container portion 52 ready for filling. The container with the first closure seal 3 and the plunger 4 can be assembled outside the aseptic environment. The container assembly is then sterilised before being filled with drug in an aseptic environment. Figure 14b shows the container portion 52 after it has been filled with drug. Figure 14c shows the lid portion 53 in position above the container portion 52 ready for assembly. Again, the entire lid assembly can advantageously be assembled outside the aseptic environment and then sterilised before being united with the container assembly in an aseptic environment. Figure 14d shows the lid portion 53 and the container portion 52 assembled together with the drug.
Figure 15 shows a section view through another example of the invention where the drug delivery device is an auto-injector. The primary drug container is significantly similar to the primary drug container of Figure 1 , and to both the primary container and needle mechanism of Figure 3, both described in detail above. A main drive spring 41 applies a force to a pusher 42, which is retained by two locking rollers 43. In order to administer the drug an auto-injector user removes the cap 44 with the attached needle shield 45 and presses the exposed front surface 46 of the needle cover 47 onto the patient injection site, pushing the needle cover 47 back into the auto-injector. This allows the locking rollers 43 to move out of the way of the pusher 42, so that the spring 41 can move the pusher 42 forwards. This in turn causes the piercing elements 48 of the pusher to pierce the first sealing element 3 and move the primary drug container axially through the auto-injector, which in turn moves the needle 15 forwards into the patient. This axial movement of the primary drug container also causes the other end of the needle 19 furthest from the patient to pierce a second sealing element 5, allowing the plunger 4 to move axially through the housing 2 and the drug 8 to be administered through a hollow hypodermic needle 15 into a patient.
Figure 16 shows Figure 15 immediately after administration of the drug to the patient. The needle 15 is extended into the patient. The other end of the needle 19 furthest from the patient has pierced the second sealing element 5 and the plunger 4 has been urged axially through the housing 2 by the pusher 42. The first sealing element 3 has been broken by the pusher piercing elements 48.
Figure 17 shows Figure 15 after the user has stopped applying the auto- injector to the skin of the patient and the needle cover spring 50 has forced the needle cover 47 to extend so that it shields the used needle 15 to reduce the risk of accidental transmission of blood-borne diseases due to needle stick injury. Locking details 51 at the back of the needle cover 47 prevent the needle cover 47 from moving back into the auto- injector.
Figure 18 is an exploded view of Figure 15 showing the components of the auto-injector. A rear cover 62, a front cover 63 and a cap 44 form the outer casing of the auto-injector. An inner housing 83 supports the spring 41.
Figure 19 shows a section view of Figure 1 incorporating an alternative design of housing 54 and second sealing element 55 where the second sealing element 55 is welded or attached with adhesive to the housing, and therefore does not require the compression washer 6 or mechanical fastening component 7 shown in Figure 1.
Figure 20 shows a section view of Figure 1 incorporating an alternative design of housing 56 and second sealing element 58 where the second sealing element 58 is attached by a mechanical fastening component 57 and compression washer 59 where the mechanical fastening component 57 is retained preferentially to the housing 56 by a screw thread 61 which engages in a corresponding thread detail 60 on the housing.
Figure 21 shows another embodiment of the invention where the opening in a housing through which the drug is filled is the same as that used to assemble the plunger.
Figure 22 is a three-dimensional section view of Figure 21 showing the components in more detail. A housing 64 is sealed by a first sealing element 65 which is retained by a compression washer 66 and mechanical fastening component 67. Inside the housing 64 a plunger 68 is positioned adjacent to the first sealing element 65, and may be attached to the sealing element 65 through a weld or adhesive. A lower body 69 is axially moveable in relation to the housing 64, and contains a needle hub 70 which in turn is axially moveable in relation to the lower body 69. A seal 71 incorporated into the needle hub 70 prevents accidental movement of the needle hub 70 before administration of the drug 72. Piercing teeth 80 on the needle hub 70 pierce the first sealing element 65 during administration of the drug, allowing the needle hub 70 to move a portion of the first sealing element 65 including the part joined to the plunger 68 and also the plunger 68 itself axially through the housing 64. A second sealing element 73 maintains the cleanliness and sterility of a needle 74 before administration of the drug 72, and is pierced by the needle 74 during administration of the drug 72. The needle 74 is fixed into the needle hub 70 so that the end of the needle 75 nearest the second sealing element 73 can enter the patient during drug administration, and so that the other end of the needle 76 furthest from the patient can pierce the first sealing element 65 during drug administration to allow the drug 72 to flow through the needle 74. A button component 77 provides a suitable surface 78 for the person administering the drug to apply a force to in order to facilitate drug administration. A locking ring 79 prevents accidental activation of the device, and is removed prior to administration of the drug 72. Figure 23 shows a section view of Figure 21 before administration of the drug 72.
Figure 24 shows a section view of Figure 21 after administration of the drug 72, and illustrates the first sealing element 65 after it has been pierced by the needle hub 70, the second sealing element 73 after it has been pierced by the needle 74, and the plunger 68 after it has been urged axially through the housing 64 by the needle hub 70 in order to deliver the drug 72.
Figure 25 shows an exploded view of Figure 21.
Figures 26a to 26d show the filling sequence for Figure 21. Figure 26a shows the container portion 81 ready for filling. Figure 26b shows the container portion 81 after it has been filled with drug 72. Figure 26c shows the lid portion 82 in position above the container portion 81 ready for assembly. Figure 26d shows the lid portion 82 and the container portion 81 assembled together with the drug 72.
As with the embodiment described with reference to Figure 14, the lid portion 82 can be preassembled outside of the aseptic environment and then sterilised before being fixed to the container portion 81 using a push- fit connection or other suitable mechanical fastening.

Claims

Claims
1. A drug dispensing device comprising: a housing containing a drug to be dispensed, the housing having a first end defining a first opening; a plunger, positioned within the housing, in contact with the drug; a first sealing element providing a first closure seal across the first opening of the housing; and a pusher initially located on an opposite side of the first seal to the plunger, wherein the pusher is operable to break the first seal and move the plunger within the housing to dispense the drug; wherein the plunger does not form a closure seal with the housing.
2 A device according to claim 1 , wherein the device comprises an auto-injector.
3. A device according to claim 1 or 2, wherein the first closure seal is substantially gas impermeable.
4. A device according to claim 1 , 2 or 3, wherein the first closure seal is sufficient to maintain the drug in a sterile condition.
5. A device according to any preceding claim, wherein the plunger is not coated in a lubricant.
6. A device according to any preceding claim, wherein the plunger has only a single continuous contact ring in contact with the housing.
7. A device according to any preceding claim, wherein the plunger forms a cup seal with the housing.
8. A device according to any preceding claim, wherein a peripheral portion of the plunger in contact with a wall of the housing comprises a substantially non-elastomeric material.
9. A device according to any preceding claim, wherein the plunger is moveable within the housing and has coefficient of friction with the housing of less than 0.3.
10. A device according to any preceding claim, wherein the plunger is moveable within the housing and has coefficient of friction with the housing of less than 0.3 when neither the plunger nor the housing is lubricated with a lubricant.
11. A device according to any preceding claim, wherein the first sealing element comprises a laminated foil.
12. A device according to claim 11 , wherein the laminated foil includes a layer of aluminium.
13. A device according to any preceding claim, wherein the first sealing element is retained by a rigid latching component acting on it through an elastic compression element.
14. A device according to any preceding claim, wherein the first sealing element is welded to the housing.
15. A device according to any one of claims 1 to 13, wherein the first sealing element is mechanically fastened to the housing.
16. A device according to any preceding claim, wherein, in use, the drug is dispensed through the first opening.
17. A device according to any one of claims 1 to 15, wherein the housing further comprises a second end defining a second opening and a second sealing element providing a second closure seal across the second opening, wherein movement of the plunger away from the first opening causes dispensing of the drug from the housing through the second opening.
18. A device according to claim 17, wherein the second sealing element is mechanically fastened to the housing.
19. A device according to claim 18, wherein the second sealing element is attached to the housing by a push-fit fastening.
20. A device according to claim 18, wherein the second sealing element is attached to the housing by a screw fitting.
21. A device according to any one of claims 17 to 20, wherein the second sealing element is retained by a rigid latching component acting on it through an elastic compression element.
22. A device according to any one of claims 17 to 21 , wherein, in use, the second closure seal is ruptured to allow the drug to be dispensed from the housing.
23. A device according to claim 22, wherein the second closure seal is ruptured by a needle, through which the drug is dispensed.
24. A device according to any preceding claim, wherein the housing is formed primarily from a plastics material.
25. A device according to claim 1 or any one of claims 3 to 24 when dependent on claim 1 , wherein the device is a non-needle based drug dispensing device.
26. A device according to claim 25, wherein the device is an inhalation, topical, nasal, oral or aural drug delivery device.
27. A primary drug container comprising: a housing containing a drug, the housing having a first end defining a first opening; a plunger, positioned within the housing, in contact with the drug; and a first sealing element providing a first closure seal across the first opening of the housing, wherein the first sealing element is rupturable; wherein the plunger does not form a closure seal with the housing.
28. A primary drug container according to claim 27, wherein the first closure seal is substantially gas impermeable.
29. A primary drug container according to claim 27 or 28, wherein the first closure seal is sufficient to maintain the drug in a sterile condition.
30. A primary drug container according to claim 27, 28 or 29, wherein the plunger is not coated in a lubricant.
31. A primary drug container according to any one of claims 27 to 30, wherein the plunger has only a single continuous contact ring in contact with the housing.
32. A primary drug container according to any one of claims 27 to 31 , wherein the plunger forms a cup seal with the housing.
33. A primary drug container according to any one of claims 27 to 32, wherein a peripheral portion of the plunger in contact with a wall of the housing comprises a substantially non-elastomeric material.
34. A primary drug container according to any one of claims 27 to 33, wherein the plunger is moveable within the housing and has coefficient of friction with the housing of less than 0.3.
35. A primary drug container according to any one of claims 27 to 34, wherein the plunger is moveable within the housing and has coefficient of friction with the housing of less than 0.3 when neither the plunger nor the housing is lubricated with a lubricant.
36. A primary drug container according to any one of claims 27 to 35, wherein the first sealing element comprises a laminated foil.
37. A primary drug container according to claim 36, wherein the laminated foil includes a layer of aluminium.
38. A primary drug container according to any one of claims 27 to 37, wherein the first sealing element is retained by a rigid latching component acting on it through an elastic compression element.
39. A primary drug container according to any one of claims 27 to 38, wherein the first sealing element is welded to the housing.
40. A primary drug container according to any one of claims 27 to 38, wherein the first sealing element is mechanically fastened to the housing.
41. A primary drug container according to any one of claims 27 to 40, wherein the housing further comprises a second end defining a second opening and a second sealing element providing a second closure seal across the second opening, wherein movement of the plunger away from the first opening causes dispensing of the drug from the housing through the second opening.
42. A primary drug container according to claim 41 , wherein the second sealing element is mechanically fastened to the housing.
43. A primary drug container according to claim 42, wherein the second sealing element is attached to the housing by a push-fit fastening.
44. A primary drug container according to claim 42, wherein the second sealing element is attached to the housing by a screw fitting.
45. A primary drug container according to any one of claims 41 to 44, wherein the second sealing element is retained by a rigid latching component acting on it through an elastic compression element.
46. A drug dispensing device comprising: a housing containing a drug to be dispensed, the housing having a first end defining a first opening and a second end defining a second opening; a plunger, positioned in the housing between the first opening and the second opening, wherein movement of the plunger away from the first opening causes dispensing of the drug from the housing through the second opening; a first sealing element providing a first seal across the first opening; a pusher initially located on an opposite side of the first seal to the plunger, wherein, in use, the pusher is operable to break the first seal and move the plunger within the housing to dispense the drug; and a second sealing element providing a second seal across the second opening, the second sealing element being attached to the housing by a mechanical fastening.
47. A device according to claim 46, wherein the first and second seals are closure seals.
48. A device according to claim 46 or 47, wherein the first seal is substantially gas impermeable.
49. A device according to any one of claims 46 to 48, wherein the first seal is sufficient to maintain the drug in a sterile condition
50. A device according to any one of claims 46 to 49, wherein the plunger is not coated in a lubricant.
51. A device according to any one of claims 46 to 50, wherein neither the plunger nor the housing is coated in a lubricant.
52. A device according to any one of claims 46 to 51 , wherein the plunger has only a single continuous sealing contact ring in contact with the housing.
53. A device according to any one of claims 46 to 52, wherein the plunger forms a cup seal with the housing.
54. A device according to any one of claims 46 to 53, wherein a peripheral portion of the plunger in contact with a wall of the housing comprises a substantially non-elastomeric material.
55. A device according to any one of claims 46 to 54 wherein the plunger is moveable within the housing and has coefficient of friction with the housing of less than 0.3.
56. A device according to any one of claims 46 to 55, wherein the first sealing element is formed from a laminated foil.
57. A device according to claim 56, wherein the laminated foil includes a layer of aluminium.
58. A device according to any one of claims 46 to 57, wherein the first sealing element is welded to the housing.
59. A device according to any one of claims 46 to 58, wherein the first sealing element is retained by a rigid latching component acting on it through an elastic compression element.
60. A device according to any one of claims 46 to 59, wherein the first sealing element is mechanically fastened to the housing.
61. A device according to any one of claims 46 to 60, wherein the second sealing element is attached to the housing by a push-fit fastening.
62. A device according to any on of claims 46 to 60, wherein the second sealing element is attached to the housing by a screw fitting.
63. A device according to any one of claims 46 to 62, wherein the second sealing element is retained by a rigid latching component acting on it through an elastic compression element.
64. A device according to any one of claims 46 to 63, wherein the device comprises a syringe.
65. A device according to any one of claims 46 to 64, wherein the device comprises an auto-injector.
66. A device according to any one of claims 46 to 65, wherein, in use, the second sealing element is ruptured to allow the drug to be dispensed from the housing.
67. A device according to claim 66, wherein the second sealing element is ruptured by a needle through which the drug is dispensed.
68. A device according to any one of claims 46 to 67, wherein the housing is formed primarily from a plastics material.
69. A method of producing a pre-filled drug delivery device, comprising the steps of: providing a device housing for containing a drug to be dispensed, the housing having a first end defining a first opening and a second end defining a second opening; providing a first seal across the first opening; inserting a plunger into the housing; inserting the drug to be dispensed into the housing through the second opening, such that the plunger is positioned between the first seal and the drug; providing a second seal across the second opening; providing a pusher that, in use, is operable to penetrate the first seal and move the plunger within the housing to cause ejection of the drug from the housing through the second opening.
70. A method according to claim 69, wherein the step of providing a first seal and the step of inserting a plunger are performed prior to the step of inserting the drug.
71. A method according to claim 69 or 70, wherein the step of providing a first seal comprises providing a first sealing element across the first opening and welding the first sealing element to the device housing.
72. A method according to any one of claims 69 to 71 , wherein the step of providing a second seal comprises providing a second sealing element across the second opening and attaching the second sealing element to the housing using a mechanical fastening.
73. A method according to claim 72, wherein the mechanical fastening is a push-fit fastening.
74. A method according to claim 72, wherein the mechanical fastening is a screw fitting.
75. A method according to any one of claims 69 to 74, further comprising the step of sterilising an interior of the housing after the step of inserting the plunger but before the step of inserting the drug.
76. A method according to any one of claims 69 to 75 wherein the steps of inserting the drug and providing the second seal are performed in a substantially sterile environment.
77. A method of producing a pre-filled primary drug container, comprising the steps of: providing a housing for containing a drug to be dispensed, the housing having a first end defining a first opening and a second end defining a second opening; providing a first seal across the first opening; inserting a plunger into the housing; inserting a drug into the housing through the second opening, such that the plunger is positioned between the first seal and the drug; and providing a second seal across the second opening;
PCT/GB2010/000282 2009-02-17 2010-02-17 Drug container and delivery mechanism WO2010094916A1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CN201080007988.4A CN102316918B (en) 2009-02-17 2010-02-17 Drug container and delivery mechanism
AU2010215317A AU2010215317A1 (en) 2009-02-17 2010-02-17 Drug container and delivery mechanism
CA2789931A CA2789931C (en) 2009-02-17 2010-02-17 Drug container and delivery mechanism
BRPI1008900A BRPI1008900B8 (en) 2009-02-17 2010-02-17 drug delivery device and primary drug container
KR1020117021732A KR101690346B1 (en) 2009-02-17 2010-02-17 Drug container and delivery mechanism
JP2011549659A JP5848132B2 (en) 2009-02-17 2010-02-17 Drug container and delivery mechanism
US13/202,007 US8632504B2 (en) 2009-02-17 2010-02-17 Drug container and delivery mechanism
EP10706709.2A EP2398534B1 (en) 2009-02-17 2010-02-17 Drug container with delivery mechanism and with a first sealing element
ZA2011/06444A ZA201106444B (en) 2009-02-17 2011-09-02 Drug container and delivery mechanism

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0902645.1A GB2467904B (en) 2009-02-17 2009-02-17 Drug container and delivery mechanism
GB0902645.1 2009-02-17

Publications (1)

Publication Number Publication Date
WO2010094916A1 true WO2010094916A1 (en) 2010-08-26

Family

ID=40548332

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2010/000282 WO2010094916A1 (en) 2009-02-17 2010-02-17 Drug container and delivery mechanism

Country Status (11)

Country Link
US (1) US8632504B2 (en)
EP (1) EP2398534B1 (en)
JP (2) JP5848132B2 (en)
KR (1) KR101690346B1 (en)
CN (1) CN102316918B (en)
AU (1) AU2010215317A1 (en)
BR (1) BRPI1008900B8 (en)
CA (1) CA2789931C (en)
GB (1) GB2467904B (en)
WO (1) WO2010094916A1 (en)
ZA (1) ZA201106444B (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011131997A1 (en) * 2010-04-23 2011-10-27 Barry Peter Liversidge Needle safety devices
WO2014060563A2 (en) 2012-10-17 2014-04-24 Oval Medical Technologies Limited Automatic drug delivery devices
WO2014076225A1 (en) 2012-11-19 2014-05-22 Carebay Europe Ltd Injection needle assembly
EP2632518B1 (en) 2010-10-14 2016-06-22 Owen Mumford Limited Injection devices
US11058820B2 (en) 2013-08-01 2021-07-13 Oval Medical Technologies Limited Drug delivery device
WO2022253525A1 (en) 2021-06-01 2022-12-08 Shl Medical Ag Medicament delivery device sub-assembly and corresponding method of assembly
US12042643B2 (en) 2018-06-22 2024-07-23 Sanofi Drug delivery device, method for manufacturing a drug delivery device and use of a welded connection

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010107761A1 (en) 2009-03-18 2010-09-23 Acelrx Pharmaceuticals, Inc. Improved storage and dispensing devices for administration of oral transmucosal dosage forms
WO2012022810A2 (en) * 2010-08-19 2012-02-23 Novo Nordisk A/S Medical injection device
CA2816832A1 (en) 2010-12-21 2012-06-28 Sanofi-Aventis Deutschland Gmbh Cartridge holder assembly for a drug delivery device
US9084849B2 (en) 2011-01-26 2015-07-21 Kaleo, Inc. Medicament delivery devices for administration of a medicament within a prefilled syringe
WO2012123565A1 (en) * 2011-03-17 2012-09-20 Sanofi-Aventis Deutschland Gmbh Drug delivery device and method of assembling the same
EP2709696B1 (en) * 2011-05-18 2022-10-26 Becton, Dickinson and Company Injection device
WO2013046855A1 (en) * 2011-09-26 2013-04-04 テルモ株式会社 Liquid injection instrument
US9522235B2 (en) 2012-05-22 2016-12-20 Kaleo, Inc. Devices and methods for delivering medicaments from a multi-chamber container
US20150217058A1 (en) 2012-09-24 2015-08-06 Enable Injections, Llc Medical vial and injector assemblies and methods of use
JP2015535456A (en) * 2012-11-23 2015-12-14 ニュー インジェクション システムズ リミテッド Self syringe assembly
US10188584B2 (en) * 2013-01-31 2019-01-29 Yiling DING Medicinal xiding vial and dispensing apparatus and injection apparatus thereof
US11246842B2 (en) 2014-12-18 2022-02-15 Windgap Medical, Inc. Method and compositions for dissolving or solubilizing therapeutic agents
US9907910B2 (en) 2013-03-15 2018-03-06 Windgap Medical, Inc. Portable drug mixing and delivery device and associated methods
WO2014146060A1 (en) 2013-03-15 2014-09-18 Windgap Medical, Inc. Portable drug mixing and delivery system and method
US10569017B2 (en) 2013-03-15 2020-02-25 Windgap Medical, Inc. Portable drug mixing and delivery device and associated methods
CA2914532C (en) * 2013-06-05 2020-12-29 Injecto A/S Piston for use in a syringe with specific dimensional ratio of a sealing structure
US9925333B2 (en) 2013-06-18 2018-03-27 Enable Injections, Inc. Vial transfer and injection apparatus and method
ES2610249T3 (en) * 2014-01-30 2017-04-26 Tecpharma Licensing Ag Release safety device for an auto-injector
EP2905040A1 (en) * 2014-02-11 2015-08-12 Sulzer Mixpac AG Discharger
US11116903B2 (en) 2014-08-18 2021-09-14 Windgap Medical, Inc Compression seal for use with a liquid component storage vial of an auto-injector
EP3183015B1 (en) 2014-08-18 2020-01-29 Windgap Medical, Inc. Portable drug mixing and delivery device and associated methods
EP3188772B1 (en) * 2014-09-05 2024-06-05 Min Wei Automatic injection device with variable dosing
KR20200103873A (en) * 2015-03-10 2020-09-02 리제너론 파아마슈티컬스, 인크. Aseptic piercing system and method
CA2980004C (en) 2015-03-24 2023-10-10 Kaleo, Inc. Devices and methods for delivering a lyophilized medicament
WO2017004345A1 (en) 2015-06-30 2017-01-05 Kaleo, Inc. Auto-injectors for administration of a medicament within a prefilled syringe
JP6580777B2 (en) 2015-08-13 2019-09-25 ウィンドギャップ メディカル， インコーポレイテッド Mixing and infusion device with aseptic characteristics
MA52369A (en) * 2015-10-30 2021-03-03 Acelrx Pharmaceuticals Inc APPARATUS AND METHODS FOR DELIVERY OF ORAL TRANSMUCOSAL DOSAGE FORMS
US20180043102A1 (en) * 2016-08-09 2018-02-15 Becton, Dickinson And Company O-Ring Plunger for a Prefilled Syringe and Method
CN109310815B (en) * 2016-09-12 2022-06-10 魏民 Drug delivery device
EP3551258A4 (en) * 2016-12-06 2020-07-22 Iinjec Technologies Inc. / Les Technologies Iinjec Inc. Method and apparatus for filling syringes with retractable needle
AU2017379094B2 (en) 2016-12-23 2023-08-24 Kaleo, Inc. Medicament delivery device and methods for delivering drugs to infants and children
CN106913925B (en) * 2017-03-30 2022-12-13 苏州林华医疗器械股份有限公司 Infusion drip chamber and infusion device thereof
KR102540409B1 (en) 2017-05-05 2023-06-09 리제너론 파아마슈티컬스, 인크. auto injector
CN108057146B (en) * 2017-12-12 2020-11-17 山西白求恩医院(山西医学科学院) Closed type needle assembly for insulin injection
KR101862679B1 (en) * 2018-05-03 2018-05-31 박영오 Syringe kit for treating keloids
CN112292168B (en) * 2018-06-22 2023-11-28 赛诺菲 Drug delivery device, method for manufacturing a drug delivery device and use of a welded connection
US11154663B2 (en) * 2018-10-25 2021-10-26 Sharps Technology Inc. Pre-filled safety needle and syringe system
JP2022543523A (en) 2019-08-09 2022-10-13 カレオ，インコーポレイテッド Device and method for delivery of substances in pre-filled syringes
EP4028083A1 (en) * 2019-09-11 2022-07-20 Eli Lilly and Company Medication delivery device with needle carrier
IT201900022548A1 (en) * 2019-11-29 2021-05-29 Fabio Giammei DISPOSABLE RETRACTABLE AND SELF-PROTECTED NEEDLE FOR SUBCUTANEOUS INJECTION
CN113144347B (en) * 2021-03-31 2022-12-09 山东恒智医创医疗器械科技有限公司 Processor for medical injector and use method thereof
JP2024519141A (en) * 2021-05-26 2024-05-08 エスエイチエル・メディカル・アーゲー Drug Delivery Module
USD1007676S1 (en) 2021-11-16 2023-12-12 Regeneron Pharmaceuticals, Inc. Wearable autoinjector

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2227020A1 (en) * 1973-04-27 1974-11-22 Radiologie Cie Gle
DE19925621A1 (en) * 1998-06-16 1999-12-23 Buelent Yilmaz Hypodermic syringe
DE10102054A1 (en) * 2001-01-17 2002-08-01 Regine Sondermann Ampule syringe in the form of an ampule has a conical section, a planned break line and a closable connector piece at one end, and a piston with a piston rod seating at the other end
EP1459775A1 (en) * 2001-12-28 2004-09-22 Terumo Kabushiki Kaisha Syringe

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58126839U (en) * 1982-02-21 1983-08-29 妹尾　信昭 Syringe
JPS62139668A (en) * 1985-12-16 1987-06-23 株式会社大協精工 Laminated plug for syringe
US4744790A (en) * 1986-08-19 1988-05-17 The West Company Fast action cartridge syringe holder
US5324272A (en) * 1990-07-27 1994-06-28 Sterling Winthrop Inc. Multiple-celled safety package, needle guard and safe disposal module for prefilled medication cartridge
EP0557344A1 (en) * 1990-11-14 1993-09-01 Duoject Medical Systems Inc Syringe
US5354286A (en) * 1993-12-07 1994-10-11 Survival Technology, Inc. Injection device having polyparaxylylene coated container
ATE195916T1 (en) * 1996-04-02 2000-09-15 Weston Medical Ltd METHOD FOR FILLING A MEDICINAL CAPSULE AND ARTICLE PRODUCED THEREFROM
JP3607464B2 (en) * 1997-07-17 2005-01-05 テルモ株式会社 Chemical injection device
JP4004106B2 (en) * 1997-07-31 2007-11-07 テルモ株式会社 Chemical injection device
US6343718B1 (en) 1998-10-15 2002-02-05 Loctite Corporation Unit dose dispense package
US6406455B1 (en) * 1998-12-18 2002-06-18 Biovalve Technologies, Inc. Injection devices
JP2003500118A (en) * 1999-05-19 2003-01-07 ウェストン メディカル リミテッド Needleless syringe drug capsule
JP2001017546A (en) * 1999-07-13 2001-01-23 Terumo Corp Drug solution dispensing device and method for manufacturing the same
JP2001029466A (en) * 1999-07-15 2001-02-06 Hiroshi Motobayashi Prefilled syringe
ATE552873T1 (en) 2002-07-02 2012-04-15 Terumo Corp SYRINGE AND PREFILLED SYRINGE
US7329240B2 (en) * 2003-01-02 2008-02-12 Meridian Medical Technologies, Inc. Protective packaging for medicament dispenser
AT500930B1 (en) 2004-10-25 2007-03-15 Pharma Consult Ges M B H & Co METHOD AND DEVICE FOR LYOPHILIZING, RECONSTITUTING AND DISTRIBUTING A RECONSTITUTED ACTIVE SUBSTANCE
JP2006116223A (en) * 2004-10-25 2006-05-11 Terumo Corp Pre-filled syringe
DE102005038495A1 (en) * 2005-08-13 2007-02-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Double chamber container and method for its filling
US7503905B2 (en) * 2005-10-03 2009-03-17 Ultradent Products, Inc. Venting syringe plunger
US9248236B2 (en) * 2010-06-24 2016-02-02 Shl Group Ab Medicament delivery device with braking means

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2227020A1 (en) * 1973-04-27 1974-11-22 Radiologie Cie Gle
DE19925621A1 (en) * 1998-06-16 1999-12-23 Buelent Yilmaz Hypodermic syringe
DE10102054A1 (en) * 2001-01-17 2002-08-01 Regine Sondermann Ampule syringe in the form of an ampule has a conical section, a planned break line and a closable connector piece at one end, and a piston with a piston rod seating at the other end
EP1459775A1 (en) * 2001-12-28 2004-09-22 Terumo Kabushiki Kaisha Syringe

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011131997A1 (en) * 2010-04-23 2011-10-27 Barry Peter Liversidge Needle safety devices
WO2011131996A1 (en) * 2010-04-23 2011-10-27 Barry Peter Liversidge Safety needle device
US10058660B2 (en) 2010-04-23 2018-08-28 Tip-Top.Com Ltd Needle safety devices
US10195362B2 (en) 2010-04-23 2019-02-05 Tip-Top.Com Ltd Safety needle device
EP2632518B1 (en) 2010-10-14 2016-06-22 Owen Mumford Limited Injection devices
WO2014060563A2 (en) 2012-10-17 2014-04-24 Oval Medical Technologies Limited Automatic drug delivery devices
EP3498322A1 (en) 2012-10-17 2019-06-19 Oval Medical Technologies Limited Automatic drug delivery devices
EP3738627A1 (en) 2012-10-17 2020-11-18 Oval Medical Technologies Limited Automatic drug delivery devices
WO2014076225A1 (en) 2012-11-19 2014-05-22 Carebay Europe Ltd Injection needle assembly
US11058820B2 (en) 2013-08-01 2021-07-13 Oval Medical Technologies Limited Drug delivery device
US12042643B2 (en) 2018-06-22 2024-07-23 Sanofi Drug delivery device, method for manufacturing a drug delivery device and use of a welded connection
WO2022253525A1 (en) 2021-06-01 2022-12-08 Shl Medical Ag Medicament delivery device sub-assembly and corresponding method of assembly

Also Published As

Publication number Publication date
BRPI1008900A2 (en) 2016-03-01
GB2467904B (en) 2013-06-12
KR101690346B1 (en) 2017-01-09
JP2012517845A (en) 2012-08-09
KR20110129400A (en) 2011-12-01
BRPI1008900B1 (en) 2020-10-06
US8632504B2 (en) 2014-01-21
CN102316918A (en) 2012-01-11
CA2789931A1 (en) 2010-08-26
CA2789931C (en) 2018-08-21
GB2467904A (en) 2010-08-18
AU2010215317A1 (en) 2011-09-22
JP6152135B2 (en) 2017-06-21
GB0902645D0 (en) 2009-04-01
JP2015178000A (en) 2015-10-08
ZA201106444B (en) 2012-05-30
BRPI1008900B8 (en) 2021-06-22
CN102316918B (en) 2014-08-27
EP2398534B1 (en) 2020-04-01
EP2398534A1 (en) 2011-12-28
JP5848132B2 (en) 2016-01-27
US20110301548A1 (en) 2011-12-08

Similar Documents

Publication Publication Date Title
CA2789931C (en) Drug container and delivery mechanism
US20220088310A1 (en) Beneficial agent dispenser
EP2445549B1 (en) A pre-filled syringe or autoinjector
US20150190588A1 (en) Insertion mechanisms having vented fluid pathways for drug delivery pumps
JP2023021444A (en) Syringe plunger stopper for high dose accuracy drug delivery
GB2547896A (en) Closure member with septum

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080007988.4

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10706709

Country of ref document: EP

Kind code of ref document: A1

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2011549659

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 13202007

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2010215317

Country of ref document: AU

Ref document number: 2010706709

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 6674/DELNP/2011

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 20117021732

Country of ref document: KR

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2010215317

Country of ref document: AU

Date of ref document: 20100217

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2789931

Country of ref document: CA

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: PI1008900

Country of ref document: BR

ENP Entry into the national phase

Ref document number: PI1008900

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20110817